BackSenhwa Biosciences Overview

Senhwa Biosciences Profit Margin

Valuation check: 6492.TWO's profit margin is -28247.43%, below the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-34357.08%
↓ 53.02% YoY

As of Jun 2026

Annual Profit Margin (TTM)

-28247.43%
↓ 1.45% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Senhwa Biosciences (6492.TWO) FAQ

The latest profit margin for 6492.TWO is -28247.43% as of June 2026. That compares with -27844.2% in the prior-year period — down 1.4% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Senhwa Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6492.TWO's profit margin moved from -27844.2% to -28247.43% — a 1.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Senhwa Biosciences's valuation or profitability profile.

Against Healthcare companies, 6492.TWO currently prints -28247.43% for profit margin, while the sector average sits near 17.63%. That is roughly 160337.3% below the sector mean. Large gaps often invite a closer look at Senhwa Biosciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Senhwa Biosciences converts resources into returns. At -28247.43%, 6492.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -27844.2% in the prior-year period — down 1.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 6492.TWO's profit margin (-28247.43%), review year-over-year change from -27844.2%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.